Search results

Skip to results

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Showing 1 to 8 of 8 results for pancreatectomy

  1. Laparoscopic distal pancreatectomy (IPG204)

    Evidence-based recommendations on laparoscopic distal pancreatectomy. This involves removing the left part of the pancreas through small cuts (keyhole surgery) in the upper abdomen.

    Interventional procedures guidance
    Published
    24 January 2007
    View recommendations

    Sections for IPG204

  2. Autologous pancreatic islet cell transplantation for improved glycaemic control after pancreatectomy (IPG274)

    Evidence-based recommendations on autologous pancreatic islet cell transplantation for improved glycaemic control after pancreatectomy. This involves removing parts of the pancreas (islet cells) after the pancreas has been removed and inserting them into the liver to restart insulin production.

    Interventional procedures guidance
    Published
    24 September 2008
    View recommendations

    Sections for IPG274

  3. Pancreatic cancer in adults: diagnosis and management (NG85)

    This guideline covers diagnosing and managing pancreatic cancer in adults aged 18 and over. It aims to improve care by ensuring quicker and more accurate diagnosis, and by specifying the most effective treatments for people depending on how advanced their cancer is.

    NICE guideline
    Published
    7 February 2018
    View recommendations

    Sections for NG85

  4. Minimally invasive pancreatectomy:- Prospective randomised trials should be undertaken to compare the effectiveness of minimally invasive pancreatectomy or pancreatoduodenectomy (laparoscopic or robotic) with open pancreatectomy or pancreatoduodenectomy in people with pancreatic cancer.

    invasive pancreatectomy:- Prospective randomised trials should be undertaken to compare the effectiveness of minimally invasive...

    Research recommendation
    Published
    13 November 2018

  5. Allogeneic pancreatic islet cell transplantation for type 1 diabetes mellitus (IPG257)

    Evidence-based recommendations on allogeneic pancreatic islet cell transplantation for type 1 diabetes mellitus. This involves removing cells called islet cells, which are responsible for the production of insulin, from human donors.

    Interventional procedures guidance
    Published
    23 April 2008
    View recommendations

    Sections for IPG257

  6. Belzutifan for treating tumours associated with von Hippel-Lindau disease (TA1011)

    Evidence-based recommendations on belzutifan (Welireg) for treating tumours associated with von Hippel-Lindau disease in adults.

    Technology appraisal guidance
    Published
    16 October 2024
    View recommendations

    Sections for TA1011

  7. Pancreatic islet cell transplantation (IPG13)

    NICE's guidance on pancreatic islet cell transplantation has now been replaced. Please go to NICE interventional procedure guidance 257 to view the full guidance on allogeneic pancreatic islet cell transplantation for type 1 diabetes mellitus and to NICE interventional procedure guidance 274 to view the full guidance on autologous pancreatic islet cell transplantation for improved glycaemic control after pancreatectomy issued to the NHS in England, Wales, Scotland and Northern Ireland.

    Interventional procedures guidance
    Published
    17 February 2003

  8. Research recommendations

    invasive pancreatectomy:- Prospective randomised trials should be undertaken to compare the effectiveness of minimally invasive...